Compare XBIO & BQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIO | BQ |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9M | 7.7M |
| IPO Year | 2011 | 2020 |
| Metric | XBIO | BQ |
|---|---|---|
| Price | $4.33 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 33.7K | ★ 76.1K |
| Earning Date | 05-13-2026 | 01-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.52 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,976,411.00 | N/A |
| Revenue This Year | $2.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.04 | N/A |
| 52 Week Low | $1.90 | $0.65 |
| 52 Week High | $13.93 | $72.74 |
| Indicator | XBIO | BQ |
|---|---|---|
| Relative Strength Index (RSI) | 56.96 | 42.12 |
| Support Level | $2.61 | $0.70 |
| Resistance Level | $4.90 | $0.89 |
| Average True Range (ATR) | 0.29 | 0.04 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 31.72 | 5.99 |
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.
Boqii Holding Ltd is a pet-focused platform in China. It offer a truly one-stop destination that pet parents in China may go to get everything it need for their pets and share their passion for pet parenting. It operate a pet-focused online retail business in China's pet market in terms of GMV. The company operates in single segment. This segment is engaged in pet products sales and online marketing and information services and other. All the company's revenues is derived from The PRC.